Phase 3 Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing to voluntarily sign a consent form agreeing to take part in the study
- People aged between 18 and 75 years old
- Women diagnosed with breast cancer (confirmed through tissue or cell testing) who are planned to receive a chemotherapy treatment called albumin paclitaxel as part of their cancer treatment, either before or after surgery
- People whose general health and ability to carry out daily activities meets a standard score of 0 or 1 on a common medical scale (confirm with trial site)
- People whose liver, kidneys, and other organs are functioning well enough to meet the trial's requirements
- People whose blood sugar control is within a certain range, specifically a blood test result called HbA1c (a measure of average blood sugar over time) must be below 7.0%
- Women who could become pregnant must agree to use effective contraception from the time they sign the consent form until 30 days after their last dose of the study drug
- People who are able to fill in questionnaires accurately to describe any nerve-related symptoms they experience, such as tingling or numbness
Who may not be able to join:
- People who already have any degree of nerve damage or numbness (called peripheral neuropathy), even mild, as measured by standard medical rating tools
- People who have other existing risk factors that could cause nerve damage, not related to chemotherapy
- People who have had a history of a different type of cancer (other than breast cancer)
- People who have muscle pain or similar symptoms in their limbs that could make it difficult to accurately assess nerve damage during the trial
- People with heart, blood vessel, or brain circulation problems that are not well controlled, or high blood pressure that is not well managed
- People who have had an active infection requiring treatment — such as a bacterial, fungal, or viral infection — within the week before starting the study drug, or who had infectious diarrhoea within the four weeks before starting the study drug
- People with inherited conditions affecting how the body processes fats and sugars, HIV infection or AIDS, a positive syphilis antibody test, active hepatitis B, or active hepatitis C
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 010-66947175
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
FACT/GOG-Ntx scores with a change of more than 12 points from the baseline
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.